eCite Digital Repository
Time to reconsider the role of sentinel lymph node biopsy in melanoma
Citation
Bigby, M and Zagarella, S and Sladden, M and Popescu, CM, Time to reconsider the role of sentinel lymph node biopsy in melanoma, Journal of the American Academy of Dermatology, 80, (4) pp. 1168-1171. ISSN 0190-9622 (2019) [Refereed Article]
Copyright Statement
Copyright 2018 American Academy of Dermatology, Inc.
DOI: doi:10.1016/j.jaad.2018.11.026
Abstract
The Multicenter Selective Lymphadenectomy Trials indicate that there are no overall or melanoma-specificsurvival advantages to performing sentinel lymph node biopsy (SLNB) followed by immediate completionlymph node dissection compared with wide excision and observation for patients with positive sentinelnodes. These results make SLNB solely a staging procedure. The role of SLNB in the management ofpatients with melanoma deserves reappraisal. The potential marginal benefit of SLNB beyond the clinicaland pathologic features of the melanoma has not been well studied. The use of sentinel lymph node statusalone to accept and stratify patients into trials or to receive adjuvant treatment is not rational.
Item Details
| Item Type: | Refereed Article |
|---|---|
| Keywords: | Breslow thickness, hazard ration, immediate completion lymph node dissection, melanoma multicenter selective lymphadenectomy trial, prognosis, sentinel lymph node biopsy, survival |
| Research Division: | Medical and Health Sciences |
| Research Group: | Public Health and Health Services |
| Research Field: | Primary Health Care |
| Objective Division: | Health |
| Objective Group: | Other Health |
| Objective Field: | Health not elsewhere classified |
| UTAS Author: | Sladden, M (Dr Mike Sladden) |
| ID Code: | 133907 |
| Year Published: | 2019 |
| Web of Science® Times Cited: | 4 |
| Deposited By: | Medicine |
| Deposited On: | 2019-07-15 |
| Last Modified: | 2019-08-22 |
| Downloads: | 0 |
Repository Staff Only: item control page